What are the current PharmaPendium content statistics?

The content release includes the following updates:

3 new drugs in PharmaPendium

• Leriglitazone Hydrochloride
• Ruxolitinib Hemifumarate
• Tafamidis

FDA Approval Documents:

• 311 new FDA Approval Documents
• 4,332 new pages of FDA Approval Documents

EMA Documents:

• 141 new EMA documents
• 718 updated EMA documents
• 5,906 new pages of EMA Documents

Extracted PK data observations:

• 5,181 new extracted PK data lines

Extracted Safety data observations:

• 17,671 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,241 new ME extracted data lines

Published Toxicity Database:

• 2,427 new safety records

Efficacy Database:

• 44,442 new extracted data lines

The new totals for PharmaPendium are:

• 3,467,597 pages of FDA Approval documents (Including FDA Classic Collection)
• 177,833 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,139 drugs with data in PharmaPendium
• 3,246,355 extracted safety data lines
• 2,535,530 extracted PK data lines
• 718,922 extracted ME data lines
• 4,633,705 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,852,503 FAERS (post-marketing) reports
• 24,382 documents / 601,754 pages of EMA Approval documents
• 22,712 documents / 852,912 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,715 FDA Guidance documents / 553 EMA Guidance documents / 432 ICH Guidance documents

The content release includes the following updates: 

9 new drugs in PharmaPendium

• Allogeneic Regulatory T Cell
• Apitegromab
• Cabozantinib Laurylsulfate
• Floretyrosine F 18
• Influenza Vaccine, mRNA
• Lirafugratinib Hydrochloride
• Pariglasgene Brecaparvovec
• Vusolimogene Oderparepvec
• Zilganersen Sodium

FDA Approval Documents:

• 386 new FDA Approval Documents
• 7,116 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 10 new FDA Advisory Committee Documents
• 79 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,463,265 pages of FDA Approval documents (Including FDA Classic Collection)
• 177,522 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,136 drugs with data in PharmaPendium
• 3,226,257 extracted safety data lines
• 2,530,349 extracted PK data lines
• 715,681 extracted ME data lines
• 4,589,263 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,852,503 FAERS (post-marketing) reports
• 24,241 documents / 595,848 pages of EMA Approval documents
• 22,712 documents / 852,912 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,708 FDA Guidance documents / 554 EMA Guidance documents / 393 ICH Guidance documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Dextromethorphan Hydrobromide; Guaifenesin; Naproxen Sodium
• Trenibotulinumtoxine

FDA Approval Documents:

• 338 new FDA Approval Documents
• 3,855 new pages of FDA Approval Documents

EMA Documents:

• 177 new EMA documents
• 5,490 new pages of EMA Documents

Extracted PK data observations:

• 4,264 new extracted PK data lines

Extracted Safety data observations:

• 5,577 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,444 new ME extracted data lines

Published Toxicity Database:

• 2,021 new safety records

The new totals for PharmaPendium are:

• 3,456,149 pages of FDA Approval documents (Including FDA Classic Collection)
• 177,136 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,127 drugs with data in PharmaPendium
• 3,226,257 extracted safety data lines
• 2,530,349 extracted PK data lines
• 715,681 extracted ME data lines
• 4,589,263 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,852,968 FAERS (post-marketing) reports
• 24,241 documents / 595,848 pages of EMA Approval documents
• 22,702 documents / 852,833 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,708 FDA Guidance documents / 554 EMA Guidance documents / 393 ICH Guidance documents

The content release includes the following updates:

12 new drugs in PharmaPendium

• Bictegravir; Lenacapavir
• Brepocitinib Tosylate
• Daraxonrasib
• Enlicitide Decanoate
• Florquinitau F-18
• Garetosmab
• Gedatolisib
• Iberdomide Hydrochloride
• Nilotinib
• Oveporexton
• Rusfertide Acetate
• Sodium Glycerophosphate

FDA Approval Documents:

• 410 new FDA Approval Documents
• 4,855 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,452,294 pages of FDA Approval documents (Including FDA Classic Collection)
• 176,798 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,125 drugs with data in PharmaPendium
• 3,218,659 extracted safety data lines
• 2,526,085 extracted PK data lines
• 714,237 extracted ME data lines
• 4,590,204 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,852,968 FAERS (post-marketing) reports
• 24,064 documents / 590,358 pages of EMA Approval documents
• 22,702 documents / 852,833 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Camizestrant
• Plozasiran Sodium
• Tolebrutinib

FDA Approval Documents:

• 387 new FDA Approval Documents
• 5,046 new pages of FDA Approval Documents

EMA Documents:

• 174 new EMA documents
• 577 updated EMA documents
• 6,151 new pages of EMA Documents

Extracted PK data observations:

• 5,835 new extracted PK data lines

Extracted Safety data observations:

• 11,532 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,389 new ME extracted data lines

Published Toxicity Database:

• 2,642 new safety records

Efficacy Database:

• 35,045 new extracted data lines

The new totals for PharmaPendium are:

• 3,447,439 pages of FDA Approval documents (Including FDA Classic Collection)
• 176,388 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,113 drugs with data in PharmaPendium
• 3,218,675 extracted safety data lines
• 2,526,085 extracted PK data lines
• 714,241 extracted ME data lines
• 4,590,204 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,853,130 FAERS (post-marketing) reports
• 24,066 documents / 590,414 pages of EMA Approval documents
• 22,702 documents / 852,833 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,703 FDA Guidance documents / 553 EMA Guidance documents / 364 ICH Guidance documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Atacicept
• Centanafadine Hydrochloride
• Veligrotug
• Zidesamtinib

FDA Approval Documents:

• 354 new FDA Approval Documents
• 4,314 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 54 new FDA Advisory Committee Documents
• 2,417 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,442,393 pages of FDA Approval documents (Including FDA Classic Collection)
• 176,001 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,110 drugs with data in PharmaPendium
• 3,204,501 extracted safety data lines
• 2,517,569 extracted PK data lines
• 711,852 extracted ME data lines
• 4,555,159 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,853,130 FAERS (post-marketing) reports
• 23,892 documents / 584,263 pages of EMA Approval documents
• 22,702 documents / 852,833 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Gadoquatrane
• Insulin Lispro Recombinant
• Tebipenem Pivoxil

FDA Approval Documents:

• 913 new FDA Approval Documents
• 12,193 new pages of FDA Approval Documents

EMA Documents:

• 84 new EMA documents
• 2,081 new pages of EMA Documents

Extracted PK data observations:

• 3,522 new extracted PK data lines

Extracted Safety data observations:

• 2,517 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,027 new ME extracted data lines

Published Toxicity Database:

• 3,834 new safety records

FAERS:

• 416,929 new FAERS reports (2026_Q2)

The new totals for PharmaPendium are:

• 3,438,079 pages of FDA Approval documents (Including FDA Classic Collection)
• 175,647 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,106 drugs with data in PharmaPendium
• 3,204,501 extracted safety data lines
• 2,517,569 extracted PK data lines
• 711,852 extracted ME data lines
• 4,555,159 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,853,130 FAERS (post-marketing) reports
• 23,892 documents / 584,263 pages of EMA Approval documents
• 22,648 documents / 850,416 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,703 FDA Guidance documents / 553 EMA Guidance documents / 364 ICH Guidance documents

The content release includes the following updates:

FDA Approval Documents:

• 457 new FDA Approval Documents
• 6,566 new pages of FDA Approval Documents

EMA Documents:

• 124 new EMA documents
• 536 updated EMA documents
• 4,290 new pages of EMA Documents

Extracted PK data observations:

• 6,924 new extracted PK data lines

Extracted Safety data observations:

• 11,759 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,245 new ME extracted data lines

Published Toxicity Database:

• 3,196 new safety records

Efficacy Database:

• 32,678 new extracted data lines

The new totals for PharmaPendium are:

• 3,425,886 pages of FDA Approval documents (Including FDA Classic Collection)
• 174,734 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,103 drugs with data in PharmaPendium
• 3,198,150 extracted safety data lines
• 2,514,047 extracted PK data lines
• 709,825 extracted ME data lines
• 4,555,159 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,436,201 FAERS (post-marketing) reports
• 23,808 documents / 582,182 pages of EMA Approval documents
• 22,648 documents / 850,416 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,690 FDA Guidance documents / 551 EMA Guidance documents / 360 ICH Guidance documents

The content release includes the following updates:

10 new drugs in PharmaPendium

• Baxdrostat
• Cipepofol
• Dolutegravir; Lamivudine; Tenofovir Disoproxil Fumarate
• Ensitrelvir
• Lunsotogene Parvec
• Marnetegragene Autotemcel
• Pivekimab Sunirine
• Sonrotoclax
• Vepdegestrant
• Zidebactam; Cefepime

FDA Approval Documents:

• 260 new FDA Approval Documents
• 2,865 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 30 new FDA Advisory Committee Documents
• 813 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,419,320 pages of FDA Approval documents (Including FDA Classic Collection)
• 174,277 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,103 drugs with data in PharmaPendium
• 3,183,195 extracted safety data lines
• 2,507,123 extracted PK data lines
• 706,580 extracted ME data lines
• 4,522,481 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,436,201 FAERS (post-marketing) reports
• 23,684 documents / 577,892 pages of EMA Approval documents
• 22,648 documents / 850,416 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,690 FDA Guidance documents / 551 EMA Guidance documents / 360 ICH Guidance documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Estetrol Monohydrate
• Influenza and Covid-19 mRNA Vaccine
• Influenza Virus Vaccine, Trivalent

FDA Approval Documents:

• 213 new FDA Approval Documents
• 4,225 new pages of FDA Approval Documents

EMA Documents:

• 174 new EMA documents
• 4,656 new pages of EMA Documents

Extracted PK data observations:

• 2,104 new extracted PK data lines

Extracted Safety data observations:

• 2,692 new extracted safety data lines

Metabolizing Enzymes Database:

• 550 new ME extracted data lines

Published Toxicity Database:

• 3,924 new safety records

The new totals for PharmaPendium are:

• 3,416,455 pages of FDA Approval documents (Including FDA Classic Collection)
• 174,017 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,093 drugs with data in PharmaPendium
• 3,184,410 extracted safety data lines
• 2,507,133 extracted PK data lines
• 706,655 extracted ME data lines
• 4,522,551 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,436,201 FAERS (post-marketing) reports
• 23,684 documents / 577,540 pages of EMA Approval documents
• 22,618 documents / 849,603 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,851 FDA Guidance documents / 576 EMA Guidance documents / 391 ICH Guidance documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Doravirine; Islatravir
• Orforglipron Calcium
• Relacorilant

FDA Approval Documents:

• 342 new FDA Approval Documents
• 4,678 new pages of FDA Approval Documents

FAERS:

• 387,470 new FAERS reports (2026_Q1 is added)

The new totals for PharmaPendium are:

• 3,412,230 pages of FDA Approval documents (Including FDA Classic Collection)
• 173,804 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,090 drugs with data in PharmaPendium
• 3,177,794 extracted safety data lines
• 2,505,029 extracted PK data lines
• 706,105 extracted ME data lines
• 4,522,551 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,436,319 FAERS (post-marketing) reports
• 23,510 documents / 572,884 pages of EMA Approval documents
• 22,618 documents / 849,603 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,851 FDA Guidance documents / 576 EMA Guidance documents / 391 ICH Guidance documents

The content release includes the following updates:

FDA Approval Documents:

• 146 new FDA Approval Documents
• 2,209 new pages of FDA Approval Documents

EMA Documents:

• 102 new EMA documents
• 730 updated EMA documents
• 3,884 new pages of EMA Documents

Extracted PK data observations:

• 6,182 new extracted PK data lines

Extracted Safety data observations:

• 12,826 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,537 new ME extracted data lines

Published Toxicity Database:

• 3,894 new safety records

Efficacy Database:

• 24,953 new extracted data lines

New Guidance Documents:

• 314 new FDA Guidance documents
• 37 new EMA Guidance documents
• 17 new ICH Guidance documents

The new totals for PharmaPendium are:

• 3,407,552 pages of FDA Approval documents (Including FDA Classic Collection)
• 173,462 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,087 drugs with data in PharmaPendium
• 3,177,794 extracted safety data lines
• 2,505,029 extracted PK data lines
• 706,114 extracted ME data lines
• 4,522,551 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,048,849 FAERS (post-marketing) reports
• 23,510 documents / 572,884 pages of EMA Approval documents
• 22,618 documents / 849,603 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,851 FDA Guidance documents / 576 EMA Guidance documents / 391 ICH Guidance documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Icotrokinra Hydrochloride
• Linerixibat
• Tividenofusp Alfa

FDA Approval Documents:

• 353 new FDA Approval Documents
• 5,053 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 16 new FDA Advisory Committee Documents
• 595 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,405,343 pages of FDA Approval documents (Including FDA Classic Collection)
• 173,316 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,087 drugs with data in PharmaPendium
• 3,161,074 extracted safety data lines
• 2,498,847 extracted PK data lines
• 702,577 extracted ME data lines
• 4,497,598 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,048,849 FAERS (post-marketing) reports
• 23,408 documents / 569,000 pages of EMA Approval documents
• 22,618 documents / 849,603 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,537 FDA Guidance documents / 539 EMA Guidance documents / 374 ICH Guidance documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Aumolertinib Mesilate
• Insulin Icodec; Semaglutide

FDA Approval Documents:

• 286 new FDA Approval Documents
• 4,076 new pages of FDA Approval Documents

EMA Documents:

• 165 new EMA documents
• 5,174 new pages of EMA Documents

Extracted PK data observations:

• 4,143 new extracted PK data lines

Extracted Safety data observations:

• 3,429 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,120 new ME extracted data lines

Published Toxicity Database:

• 4,958 new safety records

The new totals for PharmaPendium are:

• 3,400,290 pages of FDA Approval documents (Including FDA Classic Collection)
• 172,963 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,084 drugs with data in PharmaPendium
• 3,161,074 extracted safety data lines
• 2,498,847 extracted PK data lines
• 702,577 extracted ME data lines
• 4,497,598 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,048,849 FAERS (post-marketing) reports
• 23,408 documents / 569,000 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents
• 1,680 FDA Guidance documents / 547 EMA Guidance documents / 382 ICH Guidance documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Difamilast
• Milsaperidone
• Navepegritide

FDA Approval Documents:

• 256 new FDA Approval Documents
• 3,520 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,396,214 pages of FDA Approval documents (Including FDA Classic Collection)
• 172,677 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,082 drugs with data in PharmaPendium
• 3,152,687 extracted safety data lines
• 2,494,704 extracted PK data lines
• 700,457 extracted ME data lines
• 4,497,598 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,048,849 FAERS (post-marketing) reports
• 23,243 documents / 563,826 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 233 new FDA Approval Documents
• 3,056 new pages of FDA Approval Documents

EMA Documents:

• 152 new EMA documents
• 561 updated EMA documents
• 4,363 new pages of EMA Documents

Extracted PK data observations:

• 10,754 new extracted PK data lines

Extracted Safety data observations:

• 14,907 new extracted safety data lines

Metabolizing Enzymes Database:

• 4,570 new ME extracted data lines

Published Toxicity Database:

• 2,693 new safety records

Efficacy Database:

• 44,646 new extracted data lines

The new totals for PharmaPendium are:

• 3,392,694 pages of FDA Approval documents (Including FDA Classic Collection)
• 172,421 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,079 drugs with data in PharmaPendium
• 3,152,690 extracted safety data lines
• 2,494,708 extracted PK data lines
• 700,459 extracted ME data lines
• 4,497,598 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,048,849 FAERS (post-marketing) reports
• 23,243 documents / 563,826 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

5 new drugs in PharmaPendium

• Amivantamab; Hyaluronidase
• Carbachol; Brimondine Tartrate
• Copper Histidinate
• Etuvetidigene Autotemcel
• Lerodalcibep

FDA Approval Documents:

• 444 new FDA Approval Documents
• 5,399 new pages of FDA Approval Documents

FAERS:

• 379,694 new FAERS reports (2025_Q4 is added)

The new totals for PharmaPendium are:

• 3,389,638 pages of FDA Approval documents (Including FDA Classic Collection)
• 172,188 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,079 drugs with data in PharmaPendium
• 3,135,090 extracted safety data lines
• 2,483,954 extracted PK data lines
• 695,889 extracted ME data lines
• 4,452,952 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 25,048,921 FAERS (post-marketing) reports
• 23,092 documents / 559,463 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

FDA Approval Documents:

• 250 new FDA Approval Documents
• 2,760 new pages of FDA Approval Documents

EMA Documents:

• 240 new EMA documents
• 4,678 new pages of EMA Documents

Extracted PK data observations:

• 6,036 new extracted PK data lines

Extracted Safety data observations:

• 5,939 new extracted safety data lines

Metabolizing Enzymes Database:

• 714 new ME extracted data lines

Published Toxicity Database:

• 5,893 new safety records

The new totals for PharmaPendium are:

• 3,384,239 pages of FDA Approval documents (Including FDA Classic Collection)
• 171,744 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,074 drugs with data in PharmaPendium
• 3,135,090 extracted safety data lines
• 2,483,954 extracted PK data lines
• 695,902 extracted ME data lines
• 4,452,952 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 24,669,227 FAERS (post-marketing) reports
• 23,092 documents / 559,463 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Aficamten
• Depemokimab
• Etripamil
• Narsoplimab
• Tradipitant
• Zoliflodacin

FDA Approval Documents:

• 595 new FDA Approval Documents
• 7,722 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,381,479 pages of FDA Approval documents (Including FDA Classic Collection)
• 171,494 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,074 drugs with data in PharmaPendium
• 3,123,258 extracted safety data lines
• 2,477,918 extracted PK data lines
• 695,188 extracted ME data lines
• 4,452,952 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 24,669,227 FAERS (post-marketing) reports
• 22,852 documents / 554,785 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

FDA Approval Documents:

• 395 new FDA Approval Documents
• 6,812 new pages of FDA Approval Documents

EMA Documents:

• 202 new EMA documents
• 615 updated EMA documents
• 7,030 new pages of EMA Documents

Extracted PK data observations:

• 5,413 new extracted PK data lines

Extracted Safety data observations:

• 15,465 new extracted safety data lines

Metabolizing Enzymes Database:

• 5,569 new ME extracted data lines

Published Toxicity Database:

• 2,934 new safety records

Efficacy Database:

• 36,260 new extracted data lines

The new totals for PharmaPendium are:

• 3,373,757 pages of FDA Approval documents (Including FDA Classic Collection)
• 170,899 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,068 drugs with data in PharmaPendium
• 3,123,258 extracted safety data lines
• 2,477,918 extracted PK data lines
• 695,461 extracted ME data lines
• 4,452,952 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 24,669,227 FAERS (post-marketing) reports
• 22,852 documents / 554,785 pages of EMA Approval documents
• 22,602 documents / 849,008 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents